GADOVIST

1.0 mMol/ml Solution for Injection

Bayer LimitedPA1410/018/001

SPC: DATE OF REVISION OF THE TEXT

20 Aug 2015 - 29 Jun 2016	29 Jun 2016 - Present
August 2015	June 2016

« Back

Follow medicine

Print

Latest Changes to Medicine Info & SPC

29 Jun 2016
SPC: DATE OF REVISION OF THE TEXT
29 Jun 2016
SPC: Pharmacodynamic properties
25 Aug 2015
ATC Code(s)
20 Aug 2015
SPC: DATE OF REVISION OF THE TEXT
28 Jul 2015
SPC: DATE OF REVISION OF THE TEXT
28 Jul 2015
SPC: Special precautions for disposal and other handling
28 Jul 2015
SPC: Nature and contents of container
28 Jul 2015
SPC: Preclinical safety data
28 Jul 2015
SPC: Pharmacokinetic properties
28 Jul 2015
SPC: Pharmacodynamic properties
28 Jul 2015
SPC: Undesirable effects
28 Jul 2015
SPC: Special warnings and precautions for use
28 Jul 2015
SPC: Posology and method of administration
28 Jul 2015
SPC: Therapeutic Indications

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.

GADOVIST

SPC: DATE OF REVISION OF THE TEXT

Latest Changes to Medicine Info & SPC

Important information regarding cookies and the HPRA